REBLOZYL® (luspatercept-aamt) is a prescription medicine used to treat anemia (low red blood cells) in adults with beta thalassemia who need regular red blood cell (RBC) transfusions.
REBLOZYL is not for use as a substitute for RBC transfusions in people who need immediate treatment for anemia.
It is not known if REBLOZYL is safe or effective in children.
This website is best viewed using the horizontal display on your tablet device.
This website is best viewed using the vertical display on your mobile device.
Understanding the options available to help manage the symptoms can help prepare you to talk to your doctor.
Anemia is usually treated with red blood cell (RBC) transfusions. People with BT are either:
Another type of medicine for people with transfusion-dependent BT is an erythroid maturation agent (EMA), which helps RBCs to mature.
Learn more about REBLOZYL, the first and only EMA.